Literature DB >> 32361291

Effect of Danshen on TLR2-triggered inflammation in macrophages.

Tingting Ye1, Difeifei Xiong2, Libing Chen1, Yufei Li1, Shuqing Gong1, Luquan Zhang2, Bailing Li2, Jianyang Pan1, Jing Qian3, Haibin Qu1.   

Abstract

BACKGROUND: Danshen (Salvia Miltiorrhiza Radix et Rhizoma) is a valued herbal plant widely used to treat cardiovascular diseases in Asian countries. In modern medicine, innate immunity-induced inflammation is considered a risk factor for cardiovascular diseases. However, little is known about the anti-inflammatory effects and molecular mechanism of Danshen.
PURPOSE: To evaluate the molecular mechanisms of Danshen on Toll-like receptor (TLR) 2-triggered inflammation in macrophages and identify its bioactive components.
METHODS: Pam3CSK4-stimulated bone marrow-derived macrophages (BMMs) were treated with Danshen water extract (DSE), and the levels of proinflammatory cytokines (interleukin (IL)-6, IL-12 and tumor necrosis factor (TNF)-α) were measured by both real-time quantitative PCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA). RNA sequencing (RNA-seq)-based bioinformatics analyses were applied to reveal the novel molecular mechanisms of DSE, followed by western blotting for verification. Additionally, HPLC-UV analysis along with bioassays was performed to identify the bioactive ingredients of DSE.
RESULTS: The results of RT-qPCR and ELISA showed that DSE significantly inhibited proinflammatory cytokine expression in a dose-dependent manner. Transcriptome analyses revealed that a wider panel of inflammatory cytokines responded to the regulatory effect of DSE, and that the TNF signaling pathway might have played a vital role. Western blotting data confirmed the involvement of extracellular signal-regulated protein kinases (ERK) and Jun N-terminal Kinase (JNK) related singling pathway. Among the seven components identified in DSE, Danshensu (DSS) and protocatechuic aldehyde (PA) were confirmed as bioactive ones with anti-inflammatory effects.
CONCLUSION: DSE showed a promising effect against TLR2-triggered inflammation associated with the inhibition of the TNF cascade down-streamed mitogen-activated protein kinase (MAPK) signaling pathway, in which IL-6 acts as the key effective molecule, and ERK and JNK phosphorylation was inhibited. Notably, DSS and PA were considered bioactive components with anti-inflammatory bioactivity.
Copyright © 2020 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Danshen; IL-6; Inflammation; RNA-SEQ; Tnf signaling pathway

Year:  2020        PMID: 32361291     DOI: 10.1016/j.phymed.2020.153228

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  5 in total

1.  Tongluo Yishen Decoction Ameliorates Renal Fibrosis via NLRP3-Mediated Pyroptosis In Vivo and In Vitro.

Authors:  Qi Jia; Xiaoyu Zhang; Gaimei Hao; Yun Zhao; Scott Lowe; Lin Han; Jianguo Qin
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

2.  Peptidoglycan-Like Components in Z-100, Extracted from Mycobacterium tuberculosis Strain Aoyama B, Increase IL-12p40 via NOD2.

Authors:  Takayuki Horii; Yuki Orikawa; Yuta Ohira; Runa Eta; Uiko Tominaga; Takanori Sato; Takao Tanaka
Journal:  J Immunol Res       Date:  2022-06-22       Impact factor: 4.493

3.  Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia.

Authors:  Guanlin Xiao; Zhihao Zeng; Jieyi Jiang; Aili Xu; Sumei Li; Yangxue Li; Zhao Chen; Weitao Chen; Jingnian Zhang; Xiaoli Bi
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

4.  Effects of Jian Pi Qing Chang Hua Shi decoction on mucosal injuries in a 2,4,6-trinitrobenzene sulphonic acid-induced inflammatory bowel disease rat model.

Authors:  Huicun Zhang; Na Ta; Hong Shen; Hongbing Wang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

5.  Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway.

Authors:  Huaman Liu; Xinyue Zhang; Yumeng Shao; Xuehong Lin; Feng Dong; Xue Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.